Dr Lindsay Dick

Senior Research Fellow

Strathclyde Institute of Pharmacy and Biomedical Sciences

Contact

Publications

Back to staff profile

Publications

Elimination of the antimicrobial action of the organoarsenical cancer therapeutic, 4-(N-(S-glutathionylacetyl)amino) phenylarsonous acid, before finished product sterility testing: Dick Lindsay J, Gray Andrew, Ram Asha, Hume Aileen, Parris Caroline, Hogg Philip J, Elliott Moira A, Ford Steven J, Halbert Gavin W; Journal of Pharmacy and Pharmacology Vol 65, pp. 1664–1669 (2013); https://doi.org/10.1111/jphp.12143
Improved pharmaceutical stability of a boronphenylalanine mannitol formulation for boron neutron capture therapy: Halbert Gavin, Elliott Moira, Ford Steven, Dick Lindsay, Schmidt Elke; European Journal of Pharmaceutical Sciences Vol 48, pp. 735-739 (2013); https://doi.org/10.1016/j.ejps.2013.01.008
A comparative analysis of two different analysers used for determination of the Total Organic Carbon in pharmaceutical grade water: Gray Andrew, Dick Lindsay, Elliott Moira, Ford Steven, Halbert Gavin; European Journal of Parenteral and Pharmaceutical Sciences Vol 17, pp. 47-51 (2012)
Comparative analysis of TOC and conductivity analysers as applied to pharmaceutical water analysis: Gray Andrew, Dick Lindsay, Elliott Moira, Ford Steven, Halbert Gavin; UK Pharm Sci 2012 (2012)
Boron phenylalanine and related impurities: HPLC analysis, stability profile and degradation pathways: Dick Lindsay, Dooley Neil, Elliott Moira A, Ford Steven J, Gordon Malcolm R, Halbert Gavin W, Kerr William J; Journal of Pharmaceutical and Biomedical Analysis Vol 56, pp. 633-636 (2011); https://doi.org/10.1016/j.jpba.2011.06.025

More publications

Research

Back to staff profile

Projects

Covid Vaccine Project: Halbert, Gavin (Principal Investigator) Dick, Lindsay (Co-investigator) Irvine, Christopher (Co-investigator); 01-Jan-2020 - 05-Jan-2023
Cancer Research UK Formulation Unit for the pharmaceutical and bio-pharmaceutical evaluation of new anti-cancer drugs C149/A28424: Halbert, Gavin (Principal Investigator) Cygan Barlow, Paulina (Co-investigator) Dick, Lindsay (Co-investigator) Elliott, Moira (Co-investigator) Lalatsa, Aikaterini (Co-investigator); Cancer Research UK Formulation Unit Quinquennial Proposal year 1; 01-Jan-2020 - 30-Jan-2025
drug Manufacture at Formulation Unit: Halbert, Gavin (Principal Investigator) Cygan Barlow, Paulina (Co-investigator) Dick, Lindsay (Co-investigator) Elliott, Moira (Co-investigator); 13-Jan-2016 - 31-Jan-2017
Cancer Research UK Formulation - PhD Studentship: Halbert, Gavin (Principal Investigator) Dick, Lindsay (Co-investigator) Elliott, Moira (Co-investigator) Ford, Steven (Co-investigator); 01-Jan-2015 - 31-Jan-2022
Cancer Research UK Formulation Unit Programme Award (2015 - 2020) Years 1-5: Halbert, Gavin (Principal Investigator) Cygan Barlow, Paulina (Co-investigator) Dick, Lindsay (Co-investigator) Elliott, Moira (Co-investigator); 01-Jan-2015 - 31-Jan-2021
Vapourised Hydrogen Peroxide Sensor Development and Validation for Large Scale Sterilisation Units: Lengden, Michael (Principal Investigator) Dick, Lindsay (Co-investigator) Halbert, Gavin (Co-investigator) Johnstone, Walter (Co-investigator); 14-Jan-2013 - 14-Jan-2014